Item
Riboflavin (VB2)
The composition of this product is 100% Riboflavin.
Nutrient / Vitamin
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| Chifeng Pharmaceutical Co., Ltd. | 84 YiDong Street Hongshan District Chifeng, Inner Mongolia 024001 CHN |
| Fuller Enterprise USA Inc. | 1735 E. Grevillea Ct. Ontario, CA 91761 |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | Chifeng Pharmaceutical Co., Ltd. | Allergens.pdf | 9/14/2022 | 9/13/2024 |
| BSE - TSE | Chifeng Pharmaceutical Co., Ltd. | BSETSE Statement.pdf | 8/7/2019 | 8/6/2022 |
| Ingredient Statement | Fuller Enterprise USA Inc. | Composition Statement.pdf | 10/28/2021 | 10/28/2022 |
| Ingredient Statement | Chifeng Pharmaceutical Co., Ltd. | Composition Statement.pdf | 10/28/2021 | 10/28/2022 |
| Country of Origin | Fuller Enterprise USA Inc. | Country of Origin.pdf | 7/13/2022 | 7/12/2025 |
| Country of Origin | Chifeng Pharmaceutical Co., Ltd. | Country of Origin.pdf | 7/21/2022 | 7/20/2025 |
| Dietary Supplement Questionnaire | Chifeng Pharmaceutical Co., Ltd. | Dietary Supplement Questionnaire.pdf | 9/20/2022 | 9/20/2023 |
| HACCP Process Flow Diagram | Fuller Enterprise USA Inc. | Flow Chart.pdf | 7/13/2022 | 7/12/2024 |
| FSVP Assessment Form | Chifeng Pharmaceutical Co., Ltd. | FSVP Assessment Form.pdf | 9/22/2022 | 9/22/2023 |
| GRAS/NDI/ODI Statement | Fuller Enterprise USA Inc. | GRAS Statement.pdf | 10/27/2021 | 10/26/2024 |
| GRAS/NDI/ODI Statement | Chifeng Pharmaceutical Co., Ltd. | GRAS Statement.pdf | 10/27/2021 | 10/26/2024 |
| HACCP Process Flow Diagram | Chifeng Pharmaceutical Co., Ltd. | HACCP Plan.pdf | 6/30/2022 | 6/29/2024 |
| Halal | Chifeng Pharmaceutical Co., Ltd. | Halal - 2023.08.10.jpg | 8/11/2021 | 8/10/2023 |
| Heavy Metal | Chifeng Pharmaceutical Co., Ltd. | Heavy Metal Data.pdf | 5/6/2021 | 5/6/2023 |
| CoA Sample | Chifeng Pharmaceutical Co., Ltd. | HS210561.pdf | 5/24/2021 | 5/24/2023 |
| CoA Sample | Fuller Enterprise USA Inc. | HS210561.pdf | 5/24/2021 | 5/24/2023 |
| Kosher | Chifeng Pharmaceutical Co., Ltd. | Kosher - 20220630.pdf | 6/30/2022 | |
| Melamine | Fuller Enterprise USA Inc. | Melamine Free Statement.pdf | 8/13/2021 | 8/13/2022 |
| Safety Data Sheet (SDS) | Chifeng Pharmaceutical Co., Ltd. | MSDS.PDF | 9/16/2022 | 9/15/2024 |
| GMO | Fuller Enterprise USA Inc. | Non-GMO Statement.pdf | 10/12/2020 | 10/12/2022 |
| GMO | Chifeng Pharmaceutical Co., Ltd. | Non-GMO Statement.pdf | 7/23/2021 | 7/23/2023 |
| Irradiation Status Statement | Fuller Enterprise USA Inc. | Non-Irradiation Statement.pdf | 8/13/2021 | 8/13/2023 |
| Irradiation Status Statement | Chifeng Pharmaceutical Co., Ltd. | Non-Irradiation Statement.pdf | 8/13/2021 | 8/13/2023 |
| Organic | Chifeng Pharmaceutical Co., Ltd. | NotApplicable_Organic.pdf | 9/16/2022 | 9/16/2023 |
| Pesticide | Chifeng Pharmaceutical Co., Ltd. | Pesticides Statement.pdf | 11/8/2019 | 11/7/2021 |
| California Prop. 65 | Fuller Enterprise USA Inc. | Prop 65 Statement.pdf | 10/28/2021 | 10/28/2023 |
| California Prop. 65 | Chifeng Pharmaceutical Co., Ltd. | Prop 65 Statement.pdf | 10/28/2021 | 10/28/2023 |
| Residual Statement | Chifeng Pharmaceutical Co., Ltd. | Residual Solvent Statement.pdf | 8/13/2021 | 8/13/2022 |
| Product Specification Sheet | Chifeng Pharmaceutical Co., Ltd. | Specification Sheet - USP.PDF | 9/15/2022 | 9/14/2025 |
| Suitability Requirements | Chifeng Pharmaceutical Co., Ltd. | Suitability Requirements.pdf | 9/21/2022 | 9/20/2025 |
